Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
35.9M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
20.7M
-
Shares change
-
+490K
-
Total reported value, excl. options
-
$85.6M
-
Value change
-
+$3.33M
-
Number of buys
-
55
-
Number of sells
-
-17
-
Price
-
$4.13
Significant Holders of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) as of Q2 2025
92 filings reported holding BIOA - BioAge Labs, Inc. - Common Stock, par value $0.00001 per share as of Q2 2025.
BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.7M shares
of 35.9M outstanding shares and own 57.75% of the company stock.
Largest 10 shareholders include AH CAPITAL MANAGEMENT, L.L.C. (3.23M shares), Sofinnova Investments, Inc. (2.3M shares), Cormorant Asset Management, LP (2.14M shares), ADAR1 Capital Management, LLC (1.94M shares), TANG CAPITAL MANAGEMENT LLC (1.6M shares), VANGUARD GROUP INC (1.56M shares), BlackRock, Inc. (1.29M shares), ORBIMED ADVISORS LLC (922K shares), Sands Capital Alternatives, LLC (786K shares), and Pivotal bioVenture Partners Investment Advisor LLC (653K shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.